These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25332262)

  • 1. Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.
    Ferreira SC; Chachá SG; Souza FF; Teixeira AC; Santana RC; Villanova MG; Zucoloto S; Ramalho LN; Perdoná GS; Passos AD; Martinelli AL
    Ann Hepatol; 2014; 13(6):762-70. PubMed ID: 25332262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients.
    Kwak MS; Cho EJ; Jang ES; Lee JH; Yu SJ; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():23-8. PubMed ID: 22156482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
    Fung J; Seto WK; Wong DK; Lai CL; Yuen MF
    Liver Int; 2015 Mar; 35(3):854-9. PubMed ID: 24840542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
    Yeo YH; Tseng TC; Hosaka T; Cunningham C; Fung JYY; Ho HJ; Kwak MS; Trinh HN; Ungtrakul T; Yu ML; Kobayashi M; Le AK; Henry L; Li J; Zhang J; Sriprayoon T; Jeong D; Tanwandee T; Gane E; Cheung RC; Wu CY; Lok AS; Lee HS; Suzuki F; Yuen MF; Kao JH; Yang HI; Nguyen MH
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00196. PubMed ID: 33094953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
    Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
    J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.
    Liu J; Lee MH; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; Wang LY; You SL; Hsiao CK; Yang HI; Chen CJ
    J Hepatol; 2013 May; 58(5):853-60. PubMed ID: 23246508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
    Yeo YH; Ho HJ; Yang HI; Tseng TC; Hosaka T; Trinh HN; Kwak MS; Park YM; Fung JYY; Buti M; Rodríguez M; Treeprasertsuk S; Preda CM; Ungtrakul T; Charatcharoenwitthaya P; Li X; Li J; Zhang J; Le MH; Wei B; Zou B; Le A; Jeong D; Chien N; Kam L; Lee CC; Riveiro-Barciela M; Istratescu D; Sriprayoon T; Chong Y; Tanwandee T; Kobayashi M; Suzuki F; Yuen MF; Lee HS; Kao JH; Lok AS; Wu CY; Nguyen MH
    Gastroenterology; 2019 Feb; 156(3):635-646.e9. PubMed ID: 30342034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy.
    Seto WK; Wong DK; Fung J; Huang FY; Lai CL; Yuen MF
    Hepatology; 2013 Sep; 58(3):923-31. PubMed ID: 23468172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.
    Yang HI; Hung HL; Lee MH; Liu J; Jen CL; Su J; Wang LY; Lu SN; You SL; Iloeje UH; Chen CJ;
    Clin Gastroenterol Hepatol; 2012 May; 10(5):527-34.e1-2. PubMed ID: 22178461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.
    Kim GA; Lim YS; An J; Lee D; Shim JH; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
    Gut; 2014 Aug; 63(8):1325-32. PubMed ID: 24162593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
    Arai M; Togo S; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):414-8. PubMed ID: 22273987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.
    Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K
    AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B surface antigen seroclearance: Relationship to hepatitis B e-antigen seroclearance and hepatitis B e-antigen-negative hepatitis.
    Fung J; Wong DK; Seto WK; Kopaniszen M; Lai CL; Yuen MF
    Am J Gastroenterol; 2014 Nov; 109(11):1764-70. PubMed ID: 25244963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct seromarkers predict different milestones of chronic hepatitis B progression.
    Liu J; Yang HI; Lee MH; Batrla-Utermann R; Jen CL; Lu SN; Wang LY; You SL; Hsiao CK; Chen CJ;
    Hepatology; 2014 Jul; 60(1):77-86. PubMed ID: 24700432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.
    Tai DI; Tsay PK; Chen WT; Chu CM; Liaw YF
    Am J Gastroenterol; 2010 May; 105(5):1102-9. PubMed ID: 20197760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.